These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22767273)
1. MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas. Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y Mol Med Rep; 2012 Oct; 6(4):705-8. PubMed ID: 22767273 [TBL] [Abstract][Full Text] [Related]
2. Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma. Mahaffey CM; Mahaffey NC; Holland W; Zhang H; Gandara DR; Mack PC; Forman HJ J Thorac Oncol; 2012 Jan; 7(1):34-9. PubMed ID: 22089114 [TBL] [Abstract][Full Text] [Related]
3. Increased NRF2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas. Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y Mol Med Rep; 2012 Aug; 6(2):391-4. PubMed ID: 22614957 [TBL] [Abstract][Full Text] [Related]
4. Genotype analysis of the NRF2 gene mutation in lung cancer. Sasaki H; Suzuki A; Shitara M; Hikosaka Y; Okuda K; Moriyama S; Yano M; Fujii Y Int J Mol Med; 2013 May; 31(5):1135-8. PubMed ID: 23545629 [TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. Mahaffey CM; Zhang H; Rinna A; Holland W; Mack PC; Forman HJ Free Radic Biol Med; 2009 Jun; 46(12):1650-7. PubMed ID: 19345732 [TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522 [TBL] [Abstract][Full Text] [Related]
7. RagD gene expression and NRF2 mutations in lung squamous cell carcinomas. Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y Oncol Lett; 2012 Dec; 4(6):1167-1170. PubMed ID: 23226795 [TBL] [Abstract][Full Text] [Related]
8. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer. Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339 [TBL] [Abstract][Full Text] [Related]
10. NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung. Sasaki H; Hikosaka Y; Okuda K; Kawano O; Moriyama S; Yano M; Fujii Y J Thorac Oncol; 2010 Jun; 5(6):786-9. PubMed ID: 20421815 [TBL] [Abstract][Full Text] [Related]
11. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors. Chien WP; Wong RH; Cheng YW; Chen CY; Lee H Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. Kim YR; Oh JE; Kim MS; Kang MR; Park SW; Han JY; Eom HS; Yoo NJ; Lee SH J Pathol; 2010 Mar; 220(4):446-51. PubMed ID: 19967722 [TBL] [Abstract][Full Text] [Related]
13. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Jeong Y; Hoang NT; Lovejoy A; Stehr H; Newman AM; Gentles AJ; Kong W; Truong D; Martin S; Chaudhuri A; Heiser D; Zhou L; Say C; Carter JN; Hiniker SM; Loo BW; West RB; Beachy P; Alizadeh AA; Diehn M Cancer Discov; 2017 Jan; 7(1):86-101. PubMed ID: 27663899 [TBL] [Abstract][Full Text] [Related]
14. EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Sasaki H; Endo K; Konishi A; Takada M; Kawahara M; Iuchi K; Matsumura A; Okumura M; Tanaka H; Kawaguchi T; Shimizu T; Takeuchi H; Yano M; Fukai I; Fujii Y Clin Cancer Res; 2005 Apr; 11(8):2924-9. PubMed ID: 15837743 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257 [TBL] [Abstract][Full Text] [Related]
16. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Maher JM; Dieter MZ; Aleksunes LM; Slitt AL; Guo G; Tanaka Y; Scheffer GL; Chan JY; Manautou JE; Chen Y; Dalton TP; Yamamoto M; Klaassen CD Hepatology; 2007 Nov; 46(5):1597-610. PubMed ID: 17668877 [TBL] [Abstract][Full Text] [Related]
17. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma. Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511 [TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer. Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662 [TBL] [Abstract][Full Text] [Related]
20. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]